Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand 
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence 
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling 
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 
Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Tesla Launches New Model Y Variant in the US Starting at $41,990 
SALT LAKE CITY, Aug. 22, 2017 -- LifeVantage Corporation (Nasdaq:LFVN), announced today that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2017, after the stock market closes on Thursday, September 7, 2017. The Company will hold an investor conference call at 2:30 p.m. Mountain Daylight Time (4:30 p.m. Eastern Daylight Time) that same day.
Investors interested in participating in the live call can dial (800) 279-9534 from the U.S. International callers can dial (719) 457-2080. A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, September 14, 2017, by dialing (844) 512-2921 from the U.S. and entering confirmation code 2297405, or (412) 317-6671 from international locations, and entering confirmation code 2297405.
There also will be a simultaneous live webcast available on the Investor Relations section of the Company's web site at http://investor.lifevantage.com/events.cfm. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation is a science-based health, wellness and anti-aging company dedicated to helping people transform themselves internally and externally at a cellular level. Their scientifically-validated product lines include Protandim® Nrf2 and NRF1 Synergizers, TrueScience® Anti-Aging Skin Care Regimen, Petandim™ for Dogs, AXIO® Smart Energy and the PhysIQ™ Smart Weight Management System. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contacts: Cindy England Director of Investor Relations (801) 432-9036 [email protected] -or- Scott Van Winkle Managing Director, ICR (617) 956-6736 [email protected]
